文献速递呼吸道感染

新冠疫情期间流感与呼吸道合胞病毒抗体水平变化:德国图林根州诺伊施塔特前瞻性队列研究

Impact of the COVID-19 pandemic on influenza and respiratory syncytial virus antibody titres in the community: a prospective cohort study in Neustadt, Thuringia, Germany.
PubMed 文献 · Eur Respir J · 2022-11-10

该研究在德国图林根州诺伊施塔特开展前瞻性社区队列研究,评估新冠疫情期间流感与呼吸道合胞病毒(RSV)低流行对人群相应抗体水平的影响。结果显示,疫情期间流感与RSV循环缺失并未导致社区人群相应抗体水平在12个月内出现实质性下降。

要点

  • 疫情期间流感与RSV低流行未造成社区抗体水平显著下降
  • 需持续监测病原体恢复流行后的人群免疫状态
  • 既往病毒循环中断后可能出现后续严重流行季

核心结论

  • 新冠疫情期间流感与RSV循环缺失并未导致社区人群相应抗体水平在12个月内出现实质性下降。

研究设计与样本

  • 德国图林根州诺伊施塔特前瞻性社区队列研究,观察期12个月。

主要发现

  • 疫情期间流感与RSV循环明显减少,但社区相应抗体水平未出现实质性下降。
  • 研究提及既往病毒循环中断数年后可能降低人群免疫并导致后续严重流行季。

临床怎么用

  • 提示临床医生在流感与RSV恢复流行时仍需关注人群免疫状态与重症风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The lack of circulation of influenza and RSV during the COVID-19 pandemic did not result in a substantial drop in respective antibody levels in the community over 12 months https://bit.ly/3qXVLId The coronavirus disease 2019 (COVID-19) pandemic, and the subsequent infection control measures, has led to a substantial shift in the spectrum of respiratory tract infections. In many regions, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was or still is the most common viral respiratory pathogen while the circulation of influenza and respiratory syncytial virus (RSV) was decreased [1–3]. There is some evidence from the past that an interruption of viral circulation for several years may reduce the immunity of the population and lead to a consecutive severe season, as observed in the 2017–2018 season that was dominated by influenza B lineage Yamagata, which was barely present in the previous 5 years [4, 5].

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Pletz MW, Dürrwald R, Reiche J, et al. Impact of the COVID-19 pandemic on influenza and respiratory syncytial virus antibody titres in the community: a prospective cohort study in Neustadt, Thuringia, Germany. Eur Respir J. 2022. PMID: 36180083. doi:10.1183/13993003.00947-2022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。